Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue 1, 2013, Pages

  Wong, Timothy C ^a,b   Piehler, Kayla ^b   Puntil, Kathy S ^b   Moguillansky, Diego ^a,b   Meier, Christopher G ^b   Lacomis, Joan M ^a   Kellman, Peter ^c   Cook, Stephen C ^a,b   Schwartzman, David S ^a,b   Simon, Marc A ^a,b,d   Mulukutla, Suresh R ^a,b   Schelbert, Erik B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d PA 15260   (United States)

Author keywords

Cardiovascular magnetic resonance imaging; Comparative effectiveness; Echocardiography; Ejection fraction; Late gadolinium enhancement

Indexed keywords

GADOLINIUM;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; DEATH; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART TRANSPLANTATION; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY; FEMALE; GADOLINIUM; HEART DISEASES; HEART TRANSPLANTATION; HETEROCYCLIC COMPOUNDS; HUMANS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84872184913     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-15-6     Document Type: Article

References (35)

1. Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction: assessment by two- and three-dimensional echocardiography and magnetic resonance imaging. Chuang ML, Hibberd MG, Salton CJ, Beaudin RA, Riley MF, Parker RA, Douglas PS, Manning WJ, J Am Coll Cardiol 2000 35 477 484 10.1016/S0735-1097(99)00551-3 10676697 (Pubitemid 30125541)
2. Recommendations for chamber quantification: a report from the american society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. J Am Soc Echocardiogr 2005 18 1440 1463 10.1016/j.echo.2005.10.005 16376782 (Pubitemid 41821197)
3. Improved semiautomated quantification of left ventricular volumes and ejection fraction using 3-dimensional echocardiography with a full matrix-array transducer: comparison with magnetic resonance imaging. Caiani EG, Corsi C, Zamorano J, Sugeng L, MacEneaney P, Weinert L, Battani R, Gutierrez-Chico JL, Koch R, Perez de Isla L, et al. J Am Soc Echocardiogr 2005 18 779 788 10.1016/j.echo.2004.12.015 16084328 (Pubitemid 41111557)
4. Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the strong heart study. Cicala S, de Simone G, Roman MJ, Best LG, Lee ET, Wang W, Welty TK, Galloway JM, Howard BV, Devereux RB, Circulation 2007 116 143 150 10.1161/CIRCULATIONAHA.106.652149 17576870 (Pubitemid 47057519)
5. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA, Lee VV, Flamm SD, Circulation 2009 120 2069 2076 10.1161/CIRCULATIONAHA.109.852517 19901193
6. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Klem I, Shah DJ, White RD, Pennell DJ, van Rossum AC, Regenfus M, Sechtem U, Schvartzman PR, Hunold P, Croisille P, et al. Circ Cardiovasc Imaging 2011 4 610 619 10.1161/CIRCIMAGING.111.964965 21911738
7. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, Pennell DJ, Eur Heart J 2000 21 1387 1396 10.1053/euhj.2000.2011 10952828 (Pubitemid 30599134)
8. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ, Am J Cardiol 2002 90 29 34 10.1016/S0002-9149(02)02381-0 12088775 (Pubitemid 34671198)
9. Prospective or retrospective: what's in a name? Vandenbroucke JP, BMJ 1991 302 249 250 10.1136/bmj.302.6771.249 1998787
10. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG, J Biomed Inform 2009 42 377 381 10.1016/j.jbi.2008.08.010 18929686
11. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E, J Cardiovasc Magn Reson 2008 10 35 10.1186/1532-429X-10-35 18605997
12. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Kellman P, Arai AE, McVeigh ER, Aletras AH, Magn Reson Med 2002 47 372 383 10.1002/mrm.10051 11810682 (Pubitemid 34116807)
13. Motion corrected free-breathing delayed-enhancement imaging of myocardial infarction using nonrigid registration. Ledesma-Carbayo MJ, Kellman P, Hsu LY, Arai AE, McVeigh ER, J Magn Reson Imaging 2007 26 184 190 10.1002/jmri.20957 17659545 (Pubitemid 47235249)
14. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS, Stat Med 2008 27 157 172 discussion 207-112 10.1002/sim.2929 17569110 (Pubitemid 351193639)
15. A SAS® macro to compute added predictive ability of New markers predicting a dichotomous outcome [ http://analytics.ncsu.edu/sesug/2010/SDA07. Kennedy.pdf ] 23459129
16. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the american college of cardiology foundation/american heart association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, et al. Circulation 2009 119 1977 2016 19324967
17. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM, Circulation 1999 100 1992 2002 10.1161/01.CIR.100.19.1992 10556226 (Pubitemid 29529292)
18. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, Parker M, Napoli A, Judd RM, Circulation 2008 117 629 637 10.1161/CIRCULATIONAHA.107.723262 18212288
19. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Schelbert EB, Hsu LY, Anderson SA, Mohanty BD, Karim SM, Kellman P, Aletras AH, Arai AE, Circ Cardiovasc Imaging 2010 3 743 752 10.1161/CIRCIMAGING.108.835793 20847191
20. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ, et al. JAMA 2012 308 890 896 10.1001/2012.jama.11089 22948699
21. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Kwong RY, Sattar H, Wu H, Vorobiof G, Gandla V, Steel K, Siu S, Brown KA, Circulation 2008 118 1011 1020 10.1161/CIRCULATIONAHA.107.727826 18725488
22. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB, Circulation 2006 113 2733 2743 10.1161/CIRCULATIONAHA.105.570648 16754804 (Pubitemid 43947991)
23. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. Kim HW, Klem I, Shah DJ, Wu E, Meyers SN, Parker MA, Crowley AL, Bonow RO, Judd RM, Kim RJ, PLoS Med 2009 6 1000057 10.1371/journal.pmed.1000057 19381280
24. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international. Multicenter study. Klem I, Shah DJ, White RD, Pennell DJ, van Rossum AC, Regenfus M, Sechtem U, Schvartzman PR, Hunold P, Croisille P, et al. Circ Cardiovasc Imaging 2011 4 610 619 10.1161/CIRCIMAGING.111.964965 21911738
25. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM, N Engl J Med 2000 343 1445 1453 10.1056/NEJM200011163432003 11078769
26. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM, et al. Circulation 2003 108 1945 1953 10.1161/01.CIR.0000095029.57483.60 14557364 (Pubitemid 37296539)
27. The role of cardiovascular magnetic resonance imaging in heart failure. Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S, J Am Coll Cardiol 2009 54 1407 1424 10.1016/j.jacc.2009.04.094 19796734
28. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T, J Am Coll Cardiol 2004 44 1030 1035 10.1016/j.jacc.2004.05.068 15337215 (Pubitemid 39165138)
29. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, et al. Circulation 2012 126 1206 1216 10.1161/CIRCULATIONAHA. 111.089409 22851543
30. Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. White SK, Sado DM, Flett AS, Moon JC, Heart 2012 98 773 779 10.1136/heartjnl-2011-301515 22422587
31. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. Schelbert EB, Testa SM, Meier CG, Ceyrolles WJ, Levenson JE, Blair AJ, Kellman P, Jones BL, Ludwig DR, Schwartzman D, et al. J Cardiovasc Magn Reson 2011 13 16 10.1186/1532-429X-13-16 21375743
32. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC, Circulation 2010 122 138 144 10.1161/CIRCULATIONAHA.109.930636 20585010
33. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, Sibley CT, Chen MY, Bandettini WP, Arai AE, Eur Heart J 2012 33 1268 1278 10.1093/eurheartj/ehr481 22279111
34. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. Kellman P, Wilson JR, Xue H, Ugander M, Arai AE, J Cardiovasc Magn Reson 2012 14 64 10.1186/1532-429X-14-64 22967246
35. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, Arai AE, J Cardiovasc Magn Reson 2012 14 64 10.1186/1532-429X-14-64 22967246